(Reuters) - The Food and Drug Administration approved label changes incorporating lower dosages for sleep medications containing zolpidem, a drug that can continue to affect patients' mental alertness even a day after its use. Full story
The FDA is reviewing whether triclosan, an antibacterial chemical contained in liquid soap and body wash, may be ineffective or even harmful to humans. Recent studies on animals have shown an increased risk of infertility, early puberty and other hormonal issues.
President Obama is defending his administration’s decision to appeal a ruling for the Plan B pill. Alex Wagner and the NOW panel discuss.
Chris Hayes looks at the Obama administration's decision to appeal an April court ruling that ordered that Plan B be made available to women of all ages.
After years of concern about the effects of energy drinks on kids, the FDA is now focusing on caffeine in foods ranging from chips to chewing gum. Michael Jacobson, the executive director of the Center for Science in the Public Interest, warns that caffeinated snacks could cause health problems for
MSNBC’s Thomas Roberts talks to a political power panel about Rep. Paul Ryan change in opinion on gay adoption, the FDA’s groundbreaking ruling on Plan B and the situation in Syria.
This undated image made available by Teva Women's Health shows the packaging for their Plan B One-Step tablet, one of the brands known as the "morning-after pill." The Plan B morning-after pill is moving over-the-counter, a decision announced by the Food and Drug Administration just days before a c
CHICAGO, IL - APRIL 05: This photo illustration shows a package of Plan B contraceptive on April 5, 2013 in Chicago, Illinois. A federal judge in New York City has ordered the Food and Drug Administration to make Plan B contraceptive, also known as the morning after pill, available to younger teens
Staff Scientist Ji Guo inspects test tubes containing dyes in a laboratory at the U.S. Food and Drug Administration in Silver Spring, Maryland in this file photo from August 14, 2012. Picture taken August 14, 2012. The Food and Drug Administration announced a reduction of $133 million in non-user
Inside look at border inspection and testing facilities in California.